APA (7th ed.) Citation

B, S., HJ, L., CL, S., J, L., & YS, C. (2026). Patient-Derived iPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease. Journal of cellular and molecular medicine, 30(17), e71350. https://doi.org/10.1111/jcmm.71350

Chicago Style (17th ed.) Citation

B, Seol, Lim HJ, Song CL, Lee J, and Cho YS. "Patient-Derived IPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease." Journal of Cellular and Molecular Medicine 30, no. 17 (2026): e71350. https://doi.org/10.1111/jcmm.71350.

MLA (9th ed.) Citation

B, Seol, et al. "Patient-Derived IPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease." Journal of Cellular and Molecular Medicine, vol. 30, no. 17, 2026, p. e71350, https://doi.org/10.1111/jcmm.71350.